1. Home
  2. TELA

TELA

TELA Bio Inc.

Logo TELA Bio Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-24-2024 2:19pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.

Founded: 2012 Country:
N/A
Employees: N/A City: MALVERN
Market Cap: 112.7M IPO Year: 2019
Target Price: $13.67 AVG Volume (30 days): 125.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.04 EPS Growth: N/A
52 Week Low/High: $4.24 - $11.26 Next Earning Date: 01-01-0001
Revenue: $58,453,000 Revenue Growth: 41.13%
Revenue Growth (this year): 30.66% Revenue Growth (next year): 25.26%

Share on Social Networks:

Stock Insider Trading Activity of TELA Bio Inc. (TELA)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
KOBLISH ANTONY TELA Chief Executive Officer Nov 14 '23 Buy $4.54 11,000 $49,976.30 303,634 SEC Form 4